{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":37,"cheight":29,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500727.png","picWidth":40,"picHeight":29,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

聯系電話:0851-33411018(行政部)   0851-88173360(銷售部)    股票代碼:SZ 002424

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":550,"cheight":381,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889249.png","picWidth":"550","picHeight":"381","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
州百靈企業集團制藥股份有限公司
股票代碼:SZ 002424
查看更多最新公告>
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":634,"cheight":56,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500733.png","picWidth":630,"picHeight":56,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

走進百靈

專精于藥 · 專注于人

 貴州百靈企業集團制藥股份有限公司(以下簡稱“貴州百靈”)是一家從事苗藥研發、生產、銷售于一體的醫藥上市公司,注冊資本14.112億元,總資產70.59億元,員工6124人。2010年6月,公司在深圳證券交易所成功上市(股票代碼:SZ 002424)。公司明確圍繞“強化公司在苗藥領域的優勢地位,力爭成為中成藥領域具有核心競爭優勢的企業”為戰略發展目標,以實施“科技苗藥、文化苗藥、生態苗藥”為抓手,致力打造擁有大健康全產業鏈的企業集團。

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":365,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889219.png","picWidth":360,"picHeight":129,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"集團概況","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889221.png","picWidth":"373","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"集團概況","linkKey":"page","linkUrl":"page.html?id=675381845688348","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":363,"cheight":129,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"藥材基地","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889220.png","picWidth":"363","picHeight":"129","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"1","linkName":"藥材基地","linkKey":"page","linkUrl":"page.html?id=675381845688358","jsonData":{}}}
致力于推動苗藥品種的科研創新
實現傳統苗藥現代化、科技化

持續挖掘和探索苗藥寶庫,以傳承

和發揚民族醫藥文化為企業使命

布局中藥材種植產業,加強道地

藥材保護,助力產業化精準扶貧

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":754,"picHeight":61,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

產品與服務

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":754,"cheight":61,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500735.png","picWidth":752,"picHeight":61,"inpColor":"","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
  • 核心產品
  • 大健康產品
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":591,"cheight":57,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049634500734.png","picWidth":590,"picHeight":57,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

百靈動態

關注百靈了解更多最新資訊

  • 百靈新聞
  • 媒體聚焦
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":264,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591153","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114131632202.png","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591153","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591153","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":161,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591157","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114131632204.png","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591157","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591157","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":278,"cheight":162,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591161","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114131632203.png","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591161","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591161","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":164,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591165","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114131632208.png","picWidth":"260","picHeight":"980","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591165","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846661591165","openType":"1","jsonData":{}}}

貴州百靈“益腎化濁顆?!雹騜期臨床試驗方案討論會順利召開

貴州百靈“黃連解毒丸”Ⅲ期臨床試驗方案討論會順利召開

貴州百靈:咳速停糖漿推動Q4業績大增,2022年凈利預增36.87%-61.02%

安順市委副書記、市長尹恒斌到貴州百靈調研復工復產工作

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":20,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"20","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":22,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"22","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":50,"cheight":21,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":"19","picHeight":"21","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2023-02-22

2023-02-20

2023-01-31

2023-01-30

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":272,"cheight":159,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979680","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114131632203.png","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979680","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979680","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":280,"cheight":180,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846678368269","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114148409411.png","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846678368269","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846678368269","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":300,"cheight":200,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979700","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114131632203.png","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979700","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979700","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":268,"cheight":163,"picBdRadio":"0","borderType":"solid","jump":"1","definedUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979709","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/1048114148409369.jpeg","picWidth":"280","picHeight":"1080","inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true,"linkData":{"linkType":"2","linkName":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979709","linkUrl":"http://www.dilettantecollection.com/displaynews.html?newsId=950846669979709","openType":"1","jsonData":{}}}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}
{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":19,"cheight":30,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889230.webp","picWidth":19,"picHeight":22,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

2023-01-31


2022-01-25

2023-01-15

2022-12-24

中國證券報 | 貴州百靈:2022年凈利同比預增36.87%-61.02%

【新春走基層】貴州百靈:正月初二復工復產 全力確保藥品供應鏈運轉順暢

證券日報 | 貴州百靈受讓中國中醫科學院抗病毒感染新藥技術 有望填補臨床用藥空白


藍鯨財經 | 貴州百靈與九州通新簽5億元大單,保障防疫四類藥“咳速停糖漿”供應

{"img":"","passBy":"0","picBd":"0","size":"1","bdSize":"1","cwidth":751,"cheight":64,"picBdRadio":"0","borderType":"solid","jump":"0","definedUrl":"","isPicBd":"0","effectBdLine":"solid","image":"http://oss.xinghuo86.cn/666753113784399/698049642889216.png","picWidth":751,"picHeight":64,"inpColor":"#000000","color":"#000000","type":0,"effectBdColor":"#000000","hasEdit":true}

投資者關系

與您共享貴州百靈的發展和成績

99久久综合狠狠综合久久,99热亚洲色精品国产88,99久久免费只有精品国产 ilbks.com